3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
2
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER_GOV
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
2
Interventions
Docetaxel
21
Radiosurgery
20
Radiotherapy
17
Androgen Antagonists
14
Leuprolide
12
Goserelin
12
bicalutamide
11
Prednisone
9
Gonadotropin-Releasing Hormone
9
Abiraterone Acetate
9
enzalutamide
8
Surveys and Questionnaires
8
Radiotherapy, Intensity-Modulated
8
Brachytherapy
8
Blood Specimen Collection
8
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
7
Triptorelin Pamoate
7
Multiparametric Magnetic Resonance Imaging
7
abiraterone
5
pembrolizumab
4
cabazitaxel
4
Standard of Care
4
Positron Emission Tomography Computed Tomography
4
Metformin
4
Heavy Ion Radiotherapy
4
Flutamide
4
Exercise
4
Estramustine
4
luprolide acetate gel depot
3
darolutamide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Prostatic Neoplasms
×
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
×
Clear all
NCT03876912
2021-04-13
ADTPSMA2
Turku University Hospital
Phase NA
Unknown
35 enrolled
NCT03313726
2017-10-18
ADTPSMA
Turku University Hospital
Phase NA
Unknown
30 enrolled